EMEA (Europe, Middle East and Africa) Hereceptin Biosimilar Market Report 2017

October 2017 | 103 pages | ID: ECF4A624C1EPEN
QYResearch

Abstracts

In this report, the EMEA Hereceptin Biosimilar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Hereceptin Biosimilar for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Hereceptin Biosimilar market competition by top manufacturers/players, with Hereceptin Biosimilar sales volume (MT), price (K USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Mylan N.V.
• AryoGen Biopharma
• Genor Biopharma
• Celltrion Inc.
• Amgen Inc.
• Mabion S.A.
• The Instituto Vital Brazil
• F. Hoffmann-La Roche AG
• Biocon
• Gedeon Richter Plc

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (K USD/Kg), market share and growth rate of each type, primarily split into

• Tablet
• Capsule

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Hereceptin Biosimilar for each application, including

• Pharmaceuticals
• Healthcare
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Hereceptin Biosimilar Market Report 2017

1 HERECEPTIN BIOSIMILAR OVERVIEW

1.1 Product Overview and Scope of Hereceptin Biosimilar
1.2 Classification of Hereceptin Biosimilar
  1.2.1 EMEA Hereceptin Biosimilar Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Hereceptin Biosimilar Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Tablet
  1.2.4 Capsule
1.3 EMEA Hereceptin Biosimilar Market by Application/End Users
  1.3.1 EMEA Hereceptin Biosimilar Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Pharmaceuticals
  1.3.3 Healthcare
  1.3.4 Others
1.4 EMEA Hereceptin Biosimilar Market by Region
  1.4.1 EMEA Hereceptin Biosimilar Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Hereceptin Biosimilar (2012-2022)
  1.5.1 EMEA Hereceptin Biosimilar Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Hereceptin Biosimilar Revenue and Growth Rate (2012-2022)

2 EMEA HERECEPTIN BIOSIMILAR COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Hereceptin Biosimilar Market Competition by Players/Manufacturers
  2.1.1 EMEA Hereceptin Biosimilar Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Hereceptin Biosimilar Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Hereceptin Biosimilar Sale Price by Players (2012-2017)
2.2 EMEA Hereceptin Biosimilar (Volume and Value) by Type/Product Category
  2.2.1 EMEA Hereceptin Biosimilar Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Hereceptin Biosimilar Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Hereceptin Biosimilar Sale Price by Type (2012-2017)
2.3 EMEA Hereceptin Biosimilar (Volume) by Application
2.4 EMEA Hereceptin Biosimilar (Volume and Value) by Region
  2.4.1 EMEA Hereceptin Biosimilar Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Hereceptin Biosimilar Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Hereceptin Biosimilar Sales Price by Region (2012-2017)

3 EUROPE HERECEPTIN BIOSIMILAR (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Hereceptin Biosimilar Sales and Value (2012-2017)
  3.1.1 Europe Hereceptin Biosimilar Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Hereceptin Biosimilar Revenue and Growth Rate (2012-2017)
3.2 Europe Hereceptin Biosimilar Sales and Market Share by Type
3.3 Europe Hereceptin Biosimilar Sales and Market Share by Application
3.4 Europe Hereceptin Biosimilar Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Hereceptin Biosimilar Sales Volume by Countries (2012-2017)
  3.4.2 Europe Hereceptin Biosimilar Revenue by Countries (2012-2017)
  3.4.3 Germany Hereceptin Biosimilar Sales and Growth Rate (2012-2017)
  3.4.4 France Hereceptin Biosimilar Sales and Growth Rate (2012-2017)
  3.4.5 UK Hereceptin Biosimilar Sales and Growth Rate (2012-2017)
  3.4.6 Russia Hereceptin Biosimilar Sales and Growth Rate (2012-2017)
  3.4.7 Italy Hereceptin Biosimilar Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Hereceptin Biosimilar Sales and Growth Rate (2012-2017)

4 MIDDLE EAST HERECEPTIN BIOSIMILAR (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Hereceptin Biosimilar Sales and Value (2012-2017)
  4.1.1 Middle East Hereceptin Biosimilar Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Hereceptin Biosimilar Revenue and Growth Rate (2012-2017)
4.2 Middle East Hereceptin Biosimilar Sales and Market Share by Type
4.3 Middle East Hereceptin Biosimilar Sales and Market Share by Application
4.4 Middle East Hereceptin Biosimilar Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Hereceptin Biosimilar Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Hereceptin Biosimilar Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Hereceptin Biosimilar Sales and Growth Rate (2012-2017)
  4.4.4 Israel Hereceptin Biosimilar Sales and Growth Rate (2012-2017)
  4.4.5 UAE Hereceptin Biosimilar Sales and Growth Rate (2012-2017)
  4.4.6 Iran Hereceptin Biosimilar Sales and Growth Rate (2012-2017)

5 AFRICA HERECEPTIN BIOSIMILAR (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Hereceptin Biosimilar Sales and Value (2012-2017)
  5.1.1 Africa Hereceptin Biosimilar Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Hereceptin Biosimilar Revenue and Growth Rate (2012-2017)
5.2 Africa Hereceptin Biosimilar Sales and Market Share by Type
5.3 Africa Hereceptin Biosimilar Sales and Market Share by Application
5.4 Africa Hereceptin Biosimilar Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Hereceptin Biosimilar Sales Volume by Countries (2012-2017)
  5.4.2 Africa Hereceptin Biosimilar Revenue by Countries (2012-2017)
  5.4.3 South Africa Hereceptin Biosimilar Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Hereceptin Biosimilar Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Hereceptin Biosimilar Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Hereceptin Biosimilar Sales and Growth Rate (2012-2017)

6 EMEA HERECEPTIN BIOSIMILAR MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Mylan N.V.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hereceptin Biosimilar Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Mylan N.V. Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AryoGen Biopharma
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Hereceptin Biosimilar Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AryoGen Biopharma Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Genor Biopharma
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Hereceptin Biosimilar Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Genor Biopharma Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Celltrion Inc.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Hereceptin Biosimilar Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Celltrion Inc. Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Amgen Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Hereceptin Biosimilar Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Amgen Inc. Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Mabion S.A.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Hereceptin Biosimilar Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Mabion S.A. Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 The Instituto Vital Brazil
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Hereceptin Biosimilar Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 The Instituto Vital Brazil Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 F. Hoffmann-La Roche AG
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Hereceptin Biosimilar Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 F. Hoffmann-La Roche AG Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Biocon
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Hereceptin Biosimilar Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Biocon Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Gedeon Richter Plc
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Hereceptin Biosimilar Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Gedeon Richter Plc Hereceptin Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 HERECEPTIN BIOSIMILAR MANUFACTURING COST ANALYSIS

7.1 Hereceptin Biosimilar Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hereceptin Biosimilar

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hereceptin Biosimilar Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hereceptin Biosimilar Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA HERECEPTIN BIOSIMILAR MARKET FORECAST (2017-2022)

11.1 EMEA Hereceptin Biosimilar Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Hereceptin Biosimilar Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Hereceptin Biosimilar Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Hereceptin Biosimilar Price and Trend Forecast (2017-2022)
11.2 EMEA Hereceptin Biosimilar Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Hereceptin Biosimilar Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Hereceptin Biosimilar Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Hereceptin Biosimilar Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Hereceptin Biosimilar Sales Forecast by Type (2017-2022)
11.7 EMEA Hereceptin Biosimilar Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Hereceptin Biosimilar
Figure EMEA Hereceptin Biosimilar Sales Volume (MT) by Type (2012-2022)
Figure EMEA Hereceptin Biosimilar Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablet Product Picture
Figure Capsule Product Picture
Figure EMEA Hereceptin Biosimilar Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Hereceptin Biosimilar by Application in 2016
Figure Pharmaceuticals Examples
Table Key Downstream Customer in Pharmaceuticals
Figure Healthcare Examples
Table Key Downstream Customer in Healthcare
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Hereceptin Biosimilar Market Size (Million USD) by Region (2012-2022)
Figure Europe Hereceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Hereceptin Biosimilar Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Hereceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Hereceptin Biosimilar Revenue (Million USD) Status and Forecast by Countries
Figure Africa Hereceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Hereceptin Biosimilar Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Hereceptin Biosimilar Sales Volume and Growth Rate (2012-2022)
Figure EMEA Hereceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Hereceptin Biosimilar Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA Hereceptin Biosimilar Sales Volume (MT) of Major Players (2012-2017)
Table EMEA Hereceptin Biosimilar Sales Share by Players (2012-2017)
Figure 2016 Hereceptin Biosimilar Sales Share by Players
Figure 2017 Hereceptin Biosimilar Sales Share by Players
Figure EMEA Hereceptin Biosimilar Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Hereceptin Biosimilar Revenue (Million USD) by Players (2012-2017)
Table EMEA Hereceptin Biosimilar Revenue Share by Players (2012-2017)
Table 2016 EMEA Hereceptin Biosimilar Revenue Share by Players
Table 2017 EMEA Hereceptin Biosimilar Revenue Share by Players
Table EMEA Hereceptin Biosimilar Sale Price (K USD/Kg) by Players (2012-2017)
Table EMEA Hereceptin Biosimilar Sales (MT) and Market Share by Type (2012-2017)
Table EMEA Hereceptin Biosimilar Sales Share by Type (2012-2017)
Figure Sales Market Share of Hereceptin Biosimilar by Type (2012-2017)
Figure EMEA Hereceptin Biosimilar Sales Market Share by Type (2012-2017)
Table EMEA Hereceptin Biosimilar Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Hereceptin Biosimilar Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hereceptin Biosimilar by Type in 2016
Table EMEA Hereceptin Biosimilar Sale Price (K USD/Kg) by Type (2012-2017)
Table EMEA Hereceptin Biosimilar Sales (MT) and Market Share by Application (2012-2017)
Table EMEA Hereceptin Biosimilar Sales Share by Application (2012-2017)
Figure Sales Market Share of Hereceptin Biosimilar by Application (2012-2017)
Figure EMEA Hereceptin Biosimilar Sales Market Share by Application in 2016
Table EMEA Hereceptin Biosimilar Sales (MT) and Market Share by Region (2012-2017)
Table EMEA Hereceptin Biosimilar Sales Share by Region (2012-2017)
Figure Sales Market Share of Hereceptin Biosimilar by Region (2012-2017)
Figure EMEA Hereceptin Biosimilar Sales Market Share in 2016
Table EMEA Hereceptin Biosimilar Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Hereceptin Biosimilar Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Hereceptin Biosimilar by Region (2012-2017)
Figure EMEA Hereceptin Biosimilar Revenue Market Share Regions in 2016
Table EMEA Hereceptin Biosimilar Sales Price (K USD/Kg) by Region (2012-2017)
Figure Europe Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Europe Hereceptin Biosimilar Revenue and Growth Rate (2012-2017)
Table Europe Hereceptin Biosimilar Sales (MT) by Type (2012-2017)
Table Europe Hereceptin Biosimilar Market Share by Type (2012-2017)
Figure Europe Hereceptin Biosimilar Market Share by Type in 2016
Table Europe Hereceptin Biosimilar Sales (MT) by Application (2012-2017)
Table Europe Hereceptin Biosimilar Market Share by Application (2012-2017)
Figure Europe Hereceptin Biosimilar Market Share by Application in 2016
Table Europe Hereceptin Biosimilar Sales (MT) by Countries (2012-2017)
Table Europe Hereceptin Biosimilar Sales Market Share by Countries (2012-2017)
Figure Europe Hereceptin Biosimilar Sales Market Share by Countries (2012-2017)
Figure Europe Hereceptin Biosimilar Sales Market Share by Countries in 2016
Table Europe Hereceptin Biosimilar Revenue (Million USD) by Countries (2012-2017)
Table Europe Hereceptin Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Europe Hereceptin Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Europe Hereceptin Biosimilar Revenue Market Share by Countries in 2016
Figure Germany Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure France Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure UK Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Russia Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Italy Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Benelux Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Hereceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Hereceptin Biosimilar Sales (MT) by Type (2012-2017)
Table Middle East Hereceptin Biosimilar Market Share by Type (2012-2017)
Figure Middle East Hereceptin Biosimilar Market Share by Type (2012-2017)
Table Middle East Hereceptin Biosimilar Sales (MT) by Applications (2012-2017)
Table Middle East Hereceptin Biosimilar Market Share by Applications (2012-2017)
Figure Middle East Hereceptin Biosimilar Sales Market Share by Application in 2016
Table Middle East Hereceptin Biosimilar Sales Volume (MT) by Countries (2012-2017)
Table Middle East Hereceptin Biosimilar Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Hereceptin Biosimilar Sales Volume Market Share by Countries in 2016
Table Middle East Hereceptin Biosimilar Revenue (Million USD) by Countries (2012-2017)
Table Middle East Hereceptin Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Middle East Hereceptin Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Middle East Hereceptin Biosimilar Revenue Market Share by Countries in 2016
Figure Saudi Arabia Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Israel Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure UAE Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Iran Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Africa Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Africa Hereceptin Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Hereceptin Biosimilar Sales (MT) by Type (2012-2017)
Table Africa Hereceptin Biosimilar Sales Market Share by Type (2012-2017)
Figure Africa Hereceptin Biosimilar Sales Market Share by Type (2012-2017)
Figure Africa Hereceptin Biosimilar Sales Market Share by Type in 2016
Table Africa Hereceptin Biosimilar Sales (MT) by Application (2012-2017)
Table Africa Hereceptin Biosimilar Sales Market Share by Application (2012-2017)
Figure Africa Hereceptin Biosimilar Sales Market Share by Application (2012-2017)
Table Africa Hereceptin Biosimilar Sales Volume (MT) by Countries (2012-2017)
Table Africa Hereceptin Biosimilar Sales Market Share by Countries (2012-2017)
Figure Africa Hereceptin Biosimilar Sales Market Share by Countries (2012-2017)
Figure Africa Hereceptin Biosimilar Sales Market Share by Countries in 2016
Table Africa Hereceptin Biosimilar Revenue (Million USD) by Countries (2012-2017)
Table Africa Hereceptin Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Africa Hereceptin Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Africa Hereceptin Biosimilar Revenue Market Share by Countries in 2016
Figure South Africa Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Egypt Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Algeria Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Table Mylan N.V. Hereceptin Biosimilar Basic Information List
Table Mylan N.V. Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Mylan N.V. Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Mylan N.V. Hereceptin Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Mylan N.V. Hereceptin Biosimilar Revenue Market Share in EMEA (2012-2017)
Table AryoGen Biopharma Hereceptin Biosimilar Basic Information List
Table AryoGen Biopharma Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure AryoGen Biopharma Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure AryoGen Biopharma Hereceptin Biosimilar Sales Market Share in EMEA (2012-2017)
Figure AryoGen Biopharma Hereceptin Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Genor Biopharma Hereceptin Biosimilar Basic Information List
Table Genor Biopharma Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Genor Biopharma Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Genor Biopharma Hereceptin Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Genor Biopharma Hereceptin Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Celltrion Inc. Hereceptin Biosimilar Basic Information List
Table Celltrion Inc. Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Celltrion Inc. Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Celltrion Inc. Hereceptin Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Celltrion Inc. Hereceptin Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Amgen Inc. Hereceptin Biosimilar Basic Information List
Table Amgen Inc. Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Amgen Inc. Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Amgen Inc. Hereceptin Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Amgen Inc. Hereceptin Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Mabion S.A. Hereceptin Biosimilar Basic Information List
Table Mabion S.A. Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Mabion S.A. Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Mabion S.A. Hereceptin Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Mabion S.A. Hereceptin Biosimilar Revenue Market Share in EMEA (2012-2017)
Table The Instituto Vital Brazil Hereceptin Biosimilar Basic Information List
Table The Instituto Vital Brazil Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure The Instituto Vital Brazil Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure The Instituto Vital Brazil Hereceptin Biosimilar Sales Market Share in EMEA (2012-2017)
Figure The Instituto Vital Brazil Hereceptin Biosimilar Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche AG Hereceptin Biosimilar Basic Information List
Table F. Hoffmann-La Roche AG Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche AG Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche AG Hereceptin Biosimilar Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche AG Hereceptin Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Biocon Hereceptin Biosimilar Basic Information List
Table Biocon Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Biocon Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Biocon Hereceptin Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Biocon Hereceptin Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Gedeon Richter Plc Hereceptin Biosimilar Basic Information List
Table Gedeon Richter Plc Hereceptin Biosimilar Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Gedeon Richter Plc Hereceptin Biosimilar Sales (MT) and Growth Rate (2012-2017)
Figure Gedeon Richter Plc Hereceptin Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Gedeon Richter Plc Hereceptin Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hereceptin Biosimilar
Figure Manufacturing Process Analysis of Hereceptin Biosimilar
Figure Hereceptin Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Hereceptin Biosimilar Major Manufacturers in 2016
Table Major Buyers of Hereceptin Biosimilar
Table Distributors/Traders List
Figure EMEA Hereceptin Biosimilar Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Hereceptin Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Hereceptin Biosimilar Price (K USD/Kg) and Trend Forecast (2017-2022)
Table EMEA Hereceptin Biosimilar Sales (MT) Forecast by Region (2017-2022)
Figure EMEA Hereceptin Biosimilar Sales Market Share Forecast by Region (2017-2022)
Table EMEA Hereceptin Biosimilar Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Hereceptin Biosimilar Revenue Market Share Forecast by Region (2017-2022)
Table Europe Hereceptin Biosimilar Sales (MT) Forecast by Countries (2017-2022)
Figure Europe Hereceptin Biosimilar Sales Market Share Forecast by Countries (2017-2022)
Table Europe Hereceptin Biosimilar Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Hereceptin Biosimilar Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Hereceptin Biosimilar Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East Hereceptin Biosimilar Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Hereceptin Biosimilar Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Hereceptin Biosimilar Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Hereceptin Biosimilar Sales (MT) Forecast by Countries (2017-2022)
Figure Africa Hereceptin Biosimilar Sales Market Share Forecast by Countries (2017-2022)
Table Africa Hereceptin Biosimilar Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Hereceptin Biosimilar Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Hereceptin Biosimilar Sales (MT) Forecast by Type (2017-2022)
Figure EMEA Hereceptin Biosimilar Sales Market Share Forecast by Type (2017-2022)
Table EMEA Hereceptin Biosimilar Sales (MT) Forecast by Application (2017-2022)
Figure EMEA Hereceptin Biosimilar Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources